Retrieve available abstracts of 5 articles: HTML format
Single Articles
October 2025
CLEMENS MJ, Bushell M, Morley SJ Correction to: Degradation of eukaryotic polypeptide chain initiation factor
(eIF) 4G in response to induction of apoptosis in human lymphoma cell lines.
Oncogene. 2025 Oct 8. doi: 10.1038/s41388-025-03586. PubMed
April 2025
CHEN W, Jiang Y, Zeng J, Liu D, et al FDX1 promotes elesclomol-induced PANoptosis in diffuse large B-cell lymphoma via
activating IRF3/IFN-beta signaling.
Oncogene. 2025 Apr 16. doi: 10.1038/s41388-025-03366. PubMedAbstract available
January 2025
ABD-ELRAHMAN I, Nassar T, Khairi N, Perlman R, et al Correction: Novel targeted mtLivin nanoparticles treatment for disseminated
diffuse large B-cell lymphoma.
Oncogene. 2025 Jan 29. doi: 10.1038/s41388-025-03282. PubMed
November 2024
BORDONE R, Ivy DM, D'Amico R, Barba M, et al MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells
through FOXO3a-mediated autophagic adaptation.
Oncogene. 2024;43:3349-3365. PubMedAbstract available
September 2023
MOLINA E, Garcia-Gutierrez L, Junco V, Perez-Olivares M, et al MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus,
enhancing the viral infection of Burkitt lymphoma cells.
Oncogene. 2023 Sep 29. doi: 10.1038/s41388-023-02846. PubMedAbstract available